Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Ependymoma × trofosfamide × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Medulloblastoma 1 Ependymoma 1 Brain Neoplasms 1

Interventions

Temozolomide 26 Magnetic Resonance Spectroscopy 16 Cyclophosphamide 12 Etoposide 11 Radiotherapy 9 Filgrastim 9 Bevacizumab 9 Biopsy 8 Carboplatin 7 X-Rays 6 Thiotepa 6 Specimen Handling 6 Phantoms, Imaging 6 Nuclear Medicine Department, Hospital 5 Nivolumab 5 Irinotecan 5 Cisplatin 5 Carmustine 5 sargramostim 4 Peripheral Blood Stem Cell Transplantation 4 Methotrexate 4 etoposide phosphate 3 Vincristine 3 Surveys and Questionnaires 3 Radiation 3 Lapatinib 3 Gadolinium DTPA 3 Azacitidine 3 Automobiles 3 1-methyltryptophan 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00749723 2018-07-20

HIT-REZ-2005

University Hospital, Bonn

Phase 2/3 Completed

Brain Neoplasms, Ependymoma, Medulloblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡